Mitral Valve Annuloplasty Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report Download FREE Resources

Published: June 13, 2024 Report Code: GDME1759EPD-ST

Select Item

Mitral Valve Annuloplasty Devices Pipeline Market Report Overview

Mitral Valve Annuloplasty Devices consist of the annuloplasty rings and bands that are used in the repair of mitral valves. Some of the mitral valve annuloplasty devices covered in this market can be used to repair both the mitral and tricuspid valves.

The Mitral Valve Annuloplasty Devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       United States

·       Europe

·       Canada

·       China

·       Others
Key Regulatory Paths ·       510(k)

·       CE

·       MDL

·       NMPA

·       PMA
Leading Companies ·       Affluent Medical SASU

·       Anchorvalve

·       Boston Scientific Corp

·       CUBE SRL

·       HVR Cardio Oy
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Mitral Valve Annuloplasty Devices Pipeline Market Segmentation by Territories

A few of the key territories for Mitral Valve Annuloplasty Devices pipeline products are the US, Europe, Canada, and China among others. As of June 2024, the US accounts for the highest number of Mitral Valve Annuloplasty Devices pipeline products.

Mitral Valve Annuloplasty Devices Pipeline Market Analysis by Territories, 2024 (%)

Mitral Valve Annuloplasty Devices Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Mitral Valve Annuloplasty Devices Pipeline Market

Download a Free Report Sample

Mitral Valve Annuloplasty Devices Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the Mitral Valve Annuloplasty Devices pipeline market are 510(k), CE, MDL, NMPA, and PMA. As of June 2024, CE is the most followed pathway for pipeline products in the market.

Mitral Valve Annuloplasty Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Mitral Valve Annuloplasty Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Buy the Full Report for More Regulatory Path Insights into the Mitral Valve Annuloplasty Devices Pipeline Market

Download a Free Report Sample

Mitral Valve Annuloplasty Devices Pipeline Market – Competitive Landscape

A few of the key companies associated with the Mitral Valve Annuloplasty Devices pipeline market are Affluent Medical SASU, Anchorvalve, Boston Scientific Corp, CUBE SRL, and HVR Cardio Oy among others.

Boston Scientific Corp:  (Boston Scientific) is a medical technology company that develops, manufactures, and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology, and vascular surgery. Boston Scientific serves hospitals, clinics, outpatient facilities, and medical offices across the world. The company has manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia and Puerto Rico. It sells products directly and also through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific, and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.

Mitral Valve Annuloplasty Devices Pipeline Market Analysis by Companies, 2024

Mitral Valve Annuloplasty Devices Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Mitral Valve Annuloplasty Devices Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Mitral Valve Annuloplasty Devices Pipeline Market Territories Outlook

  • United States
  • Europe
  • Global
  • Canada
  • China

Mitral Valve Annuloplasty Devices Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • MDL
  • NMPA
  • PMA

Scope

This report provides:

  • Extensive coverage of the Mitral Valve Annuloplasty Devices under development.

  • The exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of Mitral Valve Annuloplasty Devices and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of Mitral Valve Annuloplasty Devices under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Affluent Medical SASU
Anchorvalve
Boston Scientific Corp
CUBE SRL
HVR Cardio Oy
MiCardia Corp
Michigan Critical Care Consultants Inc
Millipede LLC
Mitre Medical Corp
Rambam Health Care Campus
Syntach AB
Tau Pnu Medical Co., Ltd.
TransCardiac Therapeutics, LLC (Inactive)
Transmural systems LLC
TTK Healthcare Ltd
Valcare Medical
Valtech Cardio Ltd

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Mitral Valve Annuloplasty Devices Overview 8

3 Products under Development 9

3.1 Mitral Valve Annuloplasty Devices – Pipeline Products by Stage of Development 9

3.2 Mitral Valve Annuloplasty Devices – Pipeline Products by Territory 10

3.3 Mitral Valve Annuloplasty Devices – Pipeline Products by Regulatory Path 11

3.4 Mitral Valve Annuloplasty Devices – Pipeline Products by Estimated Approval Date 12

3.5 Mitral Valve Annuloplasty Devices – Ongoing Clinical Trials 13

4 Mitral Valve Annuloplasty Devices – Pipeline Products under Development by Companies 14

4.1 Mitral Valve Annuloplasty Devices Companies – Pipeline Products by Stage of Development 14

4.2 Mitral Valve Annuloplasty Devices – Pipeline Products by Stage of Development 15

5 Mitral Valve Annuloplasty Devices Companies and Product Overview 16

5.1 Affluent Medical SASU Company Overview 16

5.1.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 Anchorvalve Company Overview 17

5.2.1 Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Boston Scientific Corp Company Overview 18

5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 CUBE SRL Company Overview 20

5.4.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 HVR Cardio Oy Company Overview 21

5.5.1 HVR Cardio Oy Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 MiCardia Corp Company Overview 23

5.6.1 MiCardia Corp Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 Michigan Critical Care Consultants Inc Company Overview 24

5.7.1 Michigan Critical Care Consultants Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 Millipede LLC Company Overview 25

5.8.1 Millipede LLC Pipeline Products & Ongoing Clinical Trials Overview 25

5.9 Mitre Medical Corp Company Overview 26

5.9.1 Mitre Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 26

5.10 Rambam Health Care Campus Company Overview 30

5.10.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 30

5.11 Syntach AB Company Overview 31

5.11.1 Syntach AB Pipeline Products & Ongoing Clinical Trials Overview 31

5.12 Tau Pnu Medical Co., Ltd. Company Overview 32

5.12.1 Tau Pnu Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32

5.13 TransCardiac Therapeutics, LLC (Inactive) Company Overview 33

5.13.1 TransCardiac Therapeutics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33

5.14 Transmural systems LLC Company Overview 34

5.14.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 34

5.15 TTK Healthcare Ltd Company Overview 36

5.15.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.16 Valcare Medical Company Overview 37

5.16.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 37

5.17 Valtech Cardio Ltd Company Overview 40

5.17.1 Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

6 Mitral Valve Annuloplasty Devices- Recent Developments 43

6.1 Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team 43

6.2 Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024 43

6.3 May 14, 2024: Valcare Medical Announces Enrollment of First Two Patients in AMEND TS EU Pilot Study 43

6.4 Apr 25, 2024: Edwards Lifesciences Reports First Quarter Results 43

6.5 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer 45

6.6 Apr 22, 2024: Genesee BioMedical Receives FDA 510(k) Clearance for TransForm McCarthy Mitral Annuloplasty Ring (TF) 45

6.7 Apr 15, 2024: Edwards Lifesciences Appoints New China Head 45

6.8 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 46

6.9 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference 46

6.10 Jan 15, 2024: Affluent Medical : Pre-submission Dossier for the 510(K) of Medical Device Kaliostm Filed With FDA for Review 46

6.11 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023 47

6.12 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 47

6.13 Sep 13, 2023: Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities 47

6.14 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference 49

6.15 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 50

6.16 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 50

7 Appendix 51

7.1 Methodology 51

7.2 About GlobalData 54

7.3 Contact Us 54

7.4 Disclaimer 54

Table

Mitral Valve Annuloplasty Devices – Pipeline Products by Stage of Development 9

Mitral Valve Annuloplasty Devices – Pipeline Products by Territory 10

Mitral Valve Annuloplasty Devices – Pipeline Products by Regulatory Path 11

Mitral Valve Annuloplasty Devices – Pipeline Products by Estimated Approval Date 12

Mitral Valve Annuloplasty Devices – Ongoing Clinical Trials 13

Mitral Valve Annuloplasty Devices Companies – Pipeline Products by Stage of Development 14

Mitral Valve Annuloplasty Devices – Pipeline Products by Stage of Development 15

Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 16

Kalios – Product Status 16

Kalios – Product Description 16

Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview 17

Sutureless Mitral Valve Repair Ring – Product Status 17

Sutureless Mitral Valve Repair Ring – Product Description 17

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 18

Millipede Percutaneous Annuloplasty Ring – Product Status 18

Millipede Percutaneous Annuloplasty Ring – Product Description 19

CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview 20

Mitral-FERCube Ring – Product Status 20

Mitral-FERCube Ring – Product Description 20

HVR Cardio Oy Pipeline Products & Ongoing Clinical Trials Overview 21

CathHELIX – Product Status 21

CathHELIX – Product Description 21

Medtentia Annuloplasty Ring (MAR) – Product Status 22

Medtentia Annuloplasty Ring (MAR) – Product Description 22

MiCardia Corp Pipeline Products & Ongoing Clinical Trials Overview 23

enCorTC – Product Status 23

enCorTC – Product Description 23

Michigan Critical Care Consultants Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Percutaneous Mitral Annuloplasty Ring – Product Status 24

Percutaneous Mitral Annuloplasty Ring – Product Description 24

Millipede LLC Pipeline Products & Ongoing Clinical Trials Overview 25

IRIS Transcatheter Annuloplasty Ring – Product Status 25

IRIS Transcatheter Annuloplasty Ring – Product Description 25

Mitre Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 26

Mitral Touch – Product Status 26

Mitral Touch – Product Description 26

Next Generation Mitral Touch – Product Status 27

Next Generation Mitral Touch – Product Description 27

Mitre Medical Corp – Ongoing Clinical Trials Overview 28

Mitral Touch – ENRAPT-MR Trial: Epicardial Mitral Repair 29

Mitral Touch – ENRAPTUS Epicardial Mitral Touch System for Mitral Insufficiency 29

Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 30

Adjustable Annuloplasty Apparatus – Product Status 30

Adjustable Annuloplasty Apparatus – Product Description 30

Syntach AB Pipeline Products & Ongoing Clinical Trials Overview 31

Syntach Mitral Device (MD) – Product Status 31

Syntach Mitral Device (MD) – Product Description 31

Tau Pnu Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32

Mitral Loop Cerclage – Product Status 32

Mitral Loop Cerclage – Product Description 32

TransCardiac Therapeutics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33

MitraFlex – Product Status 33

MitraFlex – Product Description 33

Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 34

MIRTH Device – Product Status 34

MIRTH Device – Product Description 34

Transmural Cerclage – Product Status 35

Transmural Cerclage – Product Description 35

TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Mitral Annuloplasty Ring – Product Status 36

Mitral Annuloplasty Ring – Product Description 36

Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 37

Amend Mitral Valve Repair System – Product Status 37

Amend Mitral Valve Repair System – Product Description 37

Valcare Medical – Ongoing Clinical Trials Overview 38

Amend Mitral Valve Repair System – Study To Evaluate the Safety and Performance of the AMEND Trans-septal System for the Treatment of Mitral Regurgitation: AMEND TS European Pilot Study 39

Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

Edwards Cardioband Mitral Reconstruction System – Product Status 40

Edwards Cardioband Mitral Reconstruction System – Product Description 40

Valtech Cardio Ltd – Ongoing Clinical Trials Overview 41

Edwards Cardioband Mitral Reconstruction System – European Registry of Transcatheter Repair for Secondary Mitral Regurgitation 42

Edwards Cardioband Mitral Reconstruction System – Transcatheter Repair of Mitral Regurgitation with Cardioband System Post Market Study: A European Prospective, Multicenter Study to Assess Transcatheter Mitral Valve Repair with Edwards Cardioband System in Patients with Symptomatic MR 42

Glossary 53

Figures

Mitral Valve Annuloplasty Devices – Pipeline Products by Stage of Development 9

Mitral Valve Annuloplasty Devices – Pipeline Products by Territory 10

Mitral Valve Annuloplasty Devices – Pipeline Products by Regulatory Path 11

Mitral Valve Annuloplasty Devices – Pipeline Products by Estimated Approval Date 12

Mitral Valve Annuloplasty Devices – Ongoing Clinical Trials 13

Frequently asked questions

Mitral Valve Annuloplasty Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Mitral Valve Annuloplasty Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Mitral Valve Annuloplasty Devices reports
Medical Devices
New
Regulatory Approved Apps Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | September 2026
Medical Devices
New
Non-Invasive Ventilation Masks and Circuits Market Size by Segments, Share,…
$7,500 | September 2026
Medical Devices
New
Insulin Pumps and Continuous Glucose Monitors Market Size by Segments,…
$7,500 | September 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Mitral Valve Annuloplasty Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Mitral Valve Annuloplasty Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more